PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm	Active, not recruiting	Phase 2	2026-09-18		NCT06906822

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Astellas Pharma Inc	43
Grupo Español Multidisciplinar de Melanoma	4
Merck Sharp & Dohme LLC	650

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Complexo Hospitalario Universitario de A Coruña	A Coruña	Spain	1
Hospital Clinic de Barcelona	Barcelona	Spain	19
Hospital Clínico Universitario Virgen de la Arrixaca	Murcia	Spain	9
Hospital General de Valencia	Valencia	Spain	5
Hospital Universitari Dexeus	Barcelona	Spain	8
Hospital Universitario 12 de Octubre	Madrid	Spain	55
Hospital Universitario La Paz	Madrid	Spain	46
Hospital Universitario Marqués de Valdecilla	Santander	Spain	40
Hospital Universitario Miguel Servet	Zaragoza	Spain	9
Hospital Universitario Ramón y Cajal	Madrid	Spain	29
Hospital Universitario Valle de Hebrón	Barcelona	Spain	1
Hospital Virgen del Rocío	Seville	Spain	5
Institut Català D'Oncologia - Badalona	Badalona	Spain	1